Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Bleeding in the menopause; This is a spontaneous report from a non-contactable consumer (patient). A 51-year-old female patient received bnt162b2 (COMIRNATY, Solution for injection), dose 1 via an unspecified route of administration, administered in left arm at the age of 51-year-old on 01Jun2021 15:15 (Lot Number: 1D016A) as single dose for COVID-19 immunisation. Medical history included menopause. The patient was not pregnant. The patient''s concomitant medications were not reported. On 04Jun2021 the patient experienced bleeding in the menopause. The event was considered as serious as it was medically significant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of the event was reported as recovering. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166